Jeff Snyder

About Jeff Snyder

Commercial healthcare leader specializing in precision oncology diagnostics, molecular biomarker testing, and the commercialization of innovative clinical technologies. Proven track record leading regional sales organizations, scaling high-performing teams, and driving physician adoption across complex health systems.Currently serving as U.S. West Sales Director at OPKO / BioReference Laboratories, leading 11 territories commercializing the 4Kscore test. Delivered 114% year-over-year growth in 2025 and 17% growth in 2024 while expanding adoption across urology and primary care channels.Deep experience across oncology diagnostics, liquid biopsy, genomic testing, and pharmaceutical commercialization. Known for building strong physician partnerships, developing KOL networks, and translating complex clinical value propositions into scalable commercial strategies.Areas of focus include:Precision Oncology | Molecular Diagnostics | Biomarker Testing | Liquid Biopsy | Clinical Adoption | Physician Engagement | Urology & Oncology Commercialization | Payer Value Strategy | National Sales Leadership | Go-to-Market Strategy | Healthcare AI | Digital Health | Health-System PartnershipsPassionate about advancing precision medicine and helping innovative healthcare technologies reach patients through effective commercial strategy and physician adoption.

Experience

1. Director of Sales Urology West

   OPKO Health, Inc.

   Nov 2022 — Present

   As Regional Sales Director, I lead the sales efforts across 11 Urology territories, managing the promotion and sales of the 4KScore Test for prostate cancer diagnostics. My responsibilities include creating and executing sales strategies, driving market penetration, improving sales performance, and enhancing operational processes. I work closely with cross-functional teams to optimize logistics, streamline workflows, and ensure high customer satisfaction. Additionally, I focus on developing and mentoring a high-performing sales team to achieve exceptional results.Key Accomplishments:• Achieved 17% year-over-year growth in 2024, surpassing sales targets.• Developed and implemented an innovative sales model focused on active closings, leading to a 120% ROI with key opinion leaders (KOLs).• Drove a 43% increase in the PCP market by launching a targeted initiative.• Streamlined the account management process, reducing \"Test Not Performed\" samples and improving logistics efficiency.• Strengthened team collaboration and performance through coaching and development initiatives.

Education

• Westminster College (MO)

  BA, Business Management

Skills

• Management
• Team Building
• Oncology
• Urology
• Healthcare
• Neurology
• Capital Equipment
• Key Account Management
• Selling
• Sales Effectiveness
• Sales Presentations
• Market Assessments
• Allergy
• Sales
• Hospitals
• Account Management
• Medical Devices
• Marketing
• Leadership
• Training
• New Business Development
• Strategic Planning
• Sales Operations
• Sales Management
• Market Development
• Biotechnology
• Product Launch
• Strategic Selling Skills
• Consultative Selling
• Cardiology
• Managed Care
• Pharmaceutical Industry
• Sales Force Development
• Cross-Functional Team Leadership
• Pharmaceutical Sales